Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Cicadae periostracum** is the shed exoskeleton (slough) of the cicada species Cryptotympana pustulata, used as a traditional Chinese medicine (TCM) animal product. It has been employed for its **antipyretic, spasmolytic, antiasthmatic, anti-inflammatory, anticonvulsant, antiepileptic, antitussive, expectorant, antitumor, and antioxidative** properties[1][2][3]. Pharmacological studies indicate it prolongs seizure latency, exerts neuroprotection, inhibits neuronal apoptosis, suppresses oxidative stress, and modulates immune responses via the PI3K/Akt/Nrf2 pathway and antioxidant enzyme regulation[2][3]. It is also widely used in Asia to treat conditions such as convulsions, sore throat, hoarseness, skin diseases (eczema, itching), and fever[1][2][3][5]. Main active ingredients are acetyldopamine derivatives and phenols[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cicadae periostracum.